Advertisement

Spongiöse Dystrophien und mitochondriale Enzephalopathien

  • W. Paulus
Chapter

Zusammenfassung

Unter Spongiose versteht man eine lichtmikroskopisch erkennbare vakuoläre Auflockerung der grauen oder weißen Substanz des Zentralnervensystems. Es handelt sich dabei um eine sehr weit verbreitete Reaktionsform des Gewebes unterschiedlicher Pathogenese, die bei zahlreichen degenerativen, metabolischen, toxischen und traumatischen Läsionen beobachtet werden kann.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agapitos E, Pavlopoulos P M, Patsouris E, Davaris P (1997) Subacute necrotizing encephalomyelopathy (Leigh’s disease): a clinicopathologic study of ten cases. Gen Diagn Pathol 142: 335–341PubMedGoogle Scholar
  2. Albrecht J, Jones E A (1999) Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 170: 138–146PubMedCrossRefGoogle Scholar
  3. Altmann H W (1972) Glycogenhaltige Karyosphäriden in Gliakernen bei hepatogener Encephalopathie. Virchows Arch Cell Pathol 11: 263–267Google Scholar
  4. Bardosi A, Creutzfeldt W, DiMauro S et al. (1987) Myo-,neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74: 248–258PubMedCrossRefGoogle Scholar
  5. Baslow M H, Suckow R F, Sapirstein V, Hungund B L (1999) Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci 13: 47–53PubMedCrossRefGoogle Scholar
  6. Berkovic S F, Carpenter S, Evans A et al. (1989) Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 112: 1231–1260PubMedCrossRefGoogle Scholar
  7. Bleggi-Torres L F, de Medeiros B C, Werner B et al. (2000) Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 25: 301–307PubMedCrossRefGoogle Scholar
  8. Burn D J, Bates D (1998) Neurology and the kidney. J Neurol Neurosurg Psychiatry 65: 810–821PubMedCrossRefGoogle Scholar
  9. Castro-Gago M, Gonzalez-Conde V, Fernandez-Seara M J, (1999) Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases. Rev Neurol 29: 912– 917Google Scholar
  10. Chinnery P F, Howell N, Lightowlers R N, Turnbull D M (1997) Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120: 1713–1721PubMedCrossRefGoogle Scholar
  11. Chu C C, Huang C C, Fang W, Chu N S, Pang CY, Wei Y H (1997) Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 37: 110–115PubMedCrossRefGoogle Scholar
  12. Diemer N K, Klee J, Schröder H, Klinken L (1977) Glial and nerve cell changes in rats with portocaval anastomosis. Acta Neuropathol 39: 59–68PubMedCrossRefGoogle Scholar
  13. DiMauro S (2000) Mitochondrial encephalomyopathies (symposium). Brain Pathol 10: 419–472PubMedCrossRefGoogle Scholar
  14. Elpeleg O N, Shaag A (1999) The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. J Inherit Metab Dis 22: 531–534PubMedCrossRefGoogle Scholar
  15. Erbslöh F (1958) Funikuläre Spinalerkrankung. In: Scholz W, Lubarsch O, Henke F, Rössle R (Hrsg) Handbuch der speziellen pathologischen Anatomie und Histologie. Bd XIII/ 2B, Springer, Berlin Göttingen Heidelberg, S 1526–1601Google Scholar
  16. Farkas G, Marton J, Nagy Z et al. (1998) Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett 242: 147–150PubMedCrossRefGoogle Scholar
  17. Gambetti P, Mellman W J, Gonatas N K (1969) Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease). An ultrastructural study. Acta Neuropathol 12: 103–115PubMedCrossRefGoogle Scholar
  18. Gascon G G, Ozand P T, Mahdi A et al. (1990) Infantile CNS spongy degeneration — 14 cases: clinical update. Neurology 40: 1876–1882PubMedGoogle Scholar
  19. Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA-Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651–653PubMedCrossRefGoogle Scholar
  20. Goto Y, Horai S, Matsuoka T et al. (1992) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42: 545–550PubMedGoogle Scholar
  21. Haltia M, Suomalainen A, Majander A, Somer H (1992) Disorders associated with multiple deletions of mitochondrial DNA. Brain Pathol 2: 133–139PubMedCrossRefGoogle Scholar
  22. Harding B N (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 5: 273–287PubMedCrossRefGoogle Scholar
  23. Hazell A S, Butterworth R F (1999) Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 222: 99–112PubMedCrossRefGoogle Scholar
  24. Jellinger K, Seitelberger F (1977) Spongy encephalopathies in infancy: spongy degeneration of CNS and progressive infantile poliodystrophy. In: Goldensohn ES, Appel SH (eds) Scientific approaches to clinical neurology. Lea & Febiger, Philadelphia, pp 363–386Google Scholar
  25. Kageyama Y, Ichikawa K, Fujioka A et al. (1991) An autopsy case of mitochondrial encephalomyopathy with prominent degeneration in olivo-ponto-cerebellar system. Acta Neuropathol 83: 99–103PubMedCrossRefGoogle Scholar
  26. Kaul R, Gao G P, Aloya M et al. (1994) Canavan disease: mutations among Jewish and non-jewish patients. Am J Hum Genet 55: 34–41PubMedGoogle Scholar
  27. Kimura T, Budka H (1986) Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol 70: 17–21PubMedCrossRefGoogle Scholar
  28. Makino M, Horai S, Goto Y, Nonaka I (1998) Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh’s syndrome. Neuromuscul Disord 8: 149–151PubMedCrossRefGoogle Scholar
  29. Manuelidis E E, Rorke L B (1989) Transmission of Alper’s disease (chronic progressive encephalopathy) produces experimental Creutzfeldt-Jakob disease in hamsters. Neurology 39: 615–621PubMedGoogle Scholar
  30. Martinez A J (1998) The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract 194: 473–486PubMedGoogle Scholar
  31. Masters C L, Richardson E P Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101: 333–344PubMedCrossRefGoogle Scholar
  32. Matalon R, Michals K, Sebesta D et al. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 29: 463–471PubMedCrossRefGoogle Scholar
  33. McShane M A, Hammans S R, Sweeney M et al. (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with deletion of mtDNA. Am J Hum Genet 48: 39–42PubMedGoogle Scholar
  34. Mohrmann R L, Mah V, Vinters H V (1990) Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 21: 630–639PubMedCrossRefGoogle Scholar
  35. Naito E, Ito M, Yokota I et al. (1997) Biochemical and molecular analysis of an X-linked case of Leigh syndrome associated with thiamin-responsive pyruvate dehydrogenase deficiency. J Inherit Metab Dis 20: 539–548PubMedCrossRefGoogle Scholar
  36. Naviaux R K, Nyhan W L, Barshop B A et al. (1999) Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers’ syndrome. Ann Neurol 45: 54–8PubMedCrossRefGoogle Scholar
  37. Nishino I, Spinazzola A, Hirano M (1999) Thymidine Phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689–692PubMedCrossRefGoogle Scholar
  38. Ohama E, Ikuta F (1987) Involvement of choroid plexus in mitochondrial encephalomyopathy ( MELAS ). Acta Neuropathol 75: 1–7PubMedCrossRefGoogle Scholar
  39. Ohama E, Ohara S, Ikuta F et al. (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74: 226–233PubMedCrossRefGoogle Scholar
  40. Ohara S, Ohama E, Takahashi H et al. (1988) Alterations of oligodendrocytes and demyelination in the spinal cord of patients with mitochondrial encephalomyopathy. J Neurol Sci 86: 19–29PubMedCrossRefGoogle Scholar
  41. Oldfors A, Fyhr I M, Holme E, Larsson N G, Tulinius M (1990) Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol 80: 541–546PubMedCrossRefGoogle Scholar
  42. Papadopoulou L C, Sue C M, Davidson M M et al. (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23: 333–337PubMedCrossRefGoogle Scholar
  43. Paulus W, Peiffer J (1990) Intracerebral distribution of mitochondrial abnormalities in 21 cases of infantile spongy dystrophy. J Neurol Sci 95: 49–62PubMedCrossRefGoogle Scholar
  44. Peiffer J, Kustermann-Kuhn B, Mortier W et al. (1988) Mitochondrial myopathies with necrotizing encephalopathy of the Leigh type. Pathol Res Pract 183: 706–716PubMedGoogle Scholar
  45. Porteous W K, James A M, Sheard P W et al. (1998) Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 257: 192–201PubMedCrossRefGoogle Scholar
  46. Reusche E, Koch V, Friedrich H J, Nunninghoff D, Stein P, Rob P M (1996) Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy. Clin Neuropathol 15: 342–347PubMedGoogle Scholar
  47. Scalabrino G (2001) Subacute combined degeneration one century later. The neurotrophic action of cobalamin (vitamin B12) revisited. J Neuropathol Exp Neurol 60: 109–120PubMedGoogle Scholar
  48. Schachenmayr W (1987) Pankreatitis-assoziierte Hirnbefunde: gibt es eine pankreatische Encephalopathie? Verh Dtsch Ges Pathol 71: 280–283PubMedGoogle Scholar
  49. Scholtz C L, Swash M, Gray A, Kogeorgos J, Marsh F (1987) Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminium toxicity. Clin Neuropathol 6: 93–97PubMedGoogle Scholar
  50. Schwechheimer K, Hashemian A (1995) Neuropathologic findings after organ transplantation. An autopsy study. Gen Diagn Pathol 141: 35–39PubMedGoogle Scholar
  51. Shoffner J M, Lott M T, Lezza A M S et al. (1990) Myoclonic epilepsy and ragged-red fiber disease ( MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61: 931–937PubMedCrossRefGoogle Scholar
  52. Sparaco M, Bonilla E, DiMauro S, Powers J M (1993) Neuro-pathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52: 1–10PubMedCrossRefGoogle Scholar
  53. Takeda S, Wakabayashi K, Ohama E, Ikuta F (1988) Neuro-pathology of myoclonus epilepsy associated with ragged- red fibers ( Fukuhara’s disease ). Acta Neuropathol 75: 433–440PubMedCrossRefGoogle Scholar
  54. Tanahashi C, Nakayama A, Yoshida M, Ito M, Mori N, Hashizume Y (2000) MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 99: 31–38PubMedCrossRefGoogle Scholar
  55. Tiranti V, Jaksch M, Hofmann S et al. (1999) Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol 46: 161–166PubMedCrossRefGoogle Scholar
  56. Tredici G, Buccellato F R, Cavaletti G, Scalabrino G (1998) Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study. J Submicrosc Cytol Pathol 30: 165–173PubMedGoogle Scholar
  57. Van Erven P M M, Cillessen J P M, Eekhoff E M W et al. (1987) Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature. Clin Neurol Neurosurg 89: 217–230PubMedCrossRefGoogle Scholar
  58. Watanabe A, Shiota T, Tsuji T (1992) Cerebral edema during hepatic encephalopathy in fulminant hepatic failure. J Med 23: 29–38PubMedGoogle Scholar
  59. Winkelman M D, Ricanati E S (1986) Dialysis encephalopathy: neuropathological aspects. Hum Pathol 17: 823–833PubMedCrossRefGoogle Scholar
  60. Wittsack H J, Kugel H, Roth B, Heindel W (1996) Quantitative measurements with localized 1H MR spectroscopy in children with Canavan’s disease. J Magn Reson Imaging 6: 889–893PubMedCrossRefGoogle Scholar
  61. Zafeiriou D I, Kleijer W J, Maroupoulos G et al. (1999) Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain Dev 21: 205–208PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • W. Paulus

There are no affiliations available

Personalised recommendations